| Business Summary | | Closure
Medical
Corp.
develops,
manufactures,
and
commercializes
medical
tissue
adhesive
products
for
the
professional
and
OTC
markets
based
on
its
proprietary
medical
grade
cyanoacrylate
technology.
Closure
Medical
Corp.,
to
date,
has
commercialized
nonabsorbable
products
that
are
used
topically,
however
research
efforts
also
include
the
development
of
absorbable
formulations
for
internal
use.
The
Company's
medical
tissue
adhesive
products
are
DERMABOND,
SOOTHE-N-SEAL,
LIQUIDERM,
and
NEXABAND. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Closure
Medical
develops,
commercializes
and
manufactures
medical
tissue
cohesive
products
based
on
its
proprietary
cyanoacrylate
technology
to
be
used
for
human
and
veterinary
wound
closure.
For
the
six
months
ended
6/30/01,
revenues
rose
38%
to
$8.3
million.
Net
income
before
accounting
change
totaled
$710
thousand
vs.
a
loss
of
$950
thousand.
Results
reflect
the
signing
of
new
distribution
agreements,
higher
margins
and
lower
research
and
development
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Ronald Ahrens, 61 Chairman | -- | Robert Toni, 60 Pres,
CEO, Director | $303K | Benny Ward, 37 VP-Fin.,
CFO | -- | William Cotter, 50 VP
- Manufacturing and Operations | 192K | Joe Barefoot, 50 VP
- Regulatory Affairs and Quality Assurance | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|